The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
Abstract
RATIONALE: IL-17 signaling has been implicated in development and persistence of asthma. Cytokine-targeted strategies blocking IL-17 receptor signaling may be beneficial in asthma treatment. OBJECTIVES: To determine efficacy and safety of brodalumab, a human anti-IL-17 receptor A monoclonal antibody, in subjects with inadequately controlled moderate to severe asthma taking regular inhaled corticosteroids. METHODS: Three hundred two subjects were randomized to brodalumab (140, 210, or 280 mg) or placebo. Primary endpoint was change in Asthma Control Questionnaire (ACQ) score from baseline to Week 12. Secondary endpoints included FEV1, symptom scores, and symptom-free days. Prespecified subgroup analyses were conducted to identify potential responsive subpopulations. Analyses included randomized subjects receiving one or more doses of investigational product using last-observation-carried-forward imputation. MEASUREMENTS AND MAIN RESULTS: Demographics and baseline characteristics were generally balanced among groups (n = 302; n = 226 brodalumab). For the overall study population, no treatment differences were observed. Nine prespecified subgroups were examined without corrections for multiple testing. In only the high-reversibility subgroup (post-bronchodilator FEV1 improvement ≥ 20%; n = 112) was an ACQ change with nominal significance noted; ACQ responses were nominally significant in the 210-mg group (estimated treatment difference, 0.53) but not significant in the higher 280-mg group (estimated treatment difference, 0.38). Adverse events, generally balanced among groups, were most commonly asthma, upper respiratory tract infection, and injection site reaction. CONCLUSIONS: Inhibition of IL-17 receptor A did not produce a treatment effect in subjects with asthma. The results of the high-reversibility subgroup analysis are of uncertain significance, requiring further study of brodalumab in this asthma subpopulation. Clinical trial registered with www.clinicaltrials.gov (NCT01199289).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
Self-citationCan Guideline-defined Asthma Control Be Achieved?: The Gaining Optimal Asthma ControL Study
Bateman, E. D., Boushey, H. A., Bousquet, J., Busse, W. W., Clark, T. J. H., Pauwels, R. A., & Pedersen, S. E. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-033oc · Cited by 1,594
Self-citationStructure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
Juniper, E. F., Bousquet, J., Abetz, L., & Bateman, E. D. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2005.08.012 · Cited by 998
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines
Molet, S., Hamid, Q., Davoineb, F., Nutku, E., Tahaa, R., Pagé, N., Olivenstein, R., Elias, J., & Chakir, J. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.117929 · Cited by 953
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941
Chakir, J., Shannon, J., Molet, S., Fukakusa, M., Elias, J., Laviolette, M., Boulet, L.-P., & Hamid, Q. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1557 · Cited by 639
TH17-associated cytokines (IL-17A and IL-17F) in severe asthma
Al-Ramli, W., Préfontaine, D., Chouiali, F., Martin, J. G., Olivenstein, R., Lemière, C., & Hamid, Q. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.024 · Cited by 637
Interleukin-17 is a negative regulator of established allergic asthma
Schnyder-Candrian, S., Togbe, D., Couillin, I., Mercier, I., Brombacher, F., Quesniaux, V., Fossiez, F., Ryffel, B., & Schnyder, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061401 · Cited by 564
Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study
Partridge, M. R., van der Molen, T., Myrseth, S.-E., & Busse, W. W. (2006) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-6-13 · Cited by 495
Self-citationKudo, M., Melton, A. C., Chen, C., Engler, M. B., Huang, K. E., Ren, X., Wang, Y., Bernstein, X., Li, J. T., Atabai, K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2684 · Cited by 446
Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine
BARCZYK, A., PIERZCHALA, W., & SOZAÑSKA, E. (2003) · Respiratory Medicine · doi:10.1053/rmed.2003.1507 · Cited by 363
Rickel, E. A., Siegel, L. A., Yoon, B.-R. P., Rottman, J. B., Kugler, D. G., Swart, D. A., Anders, P. M., Tocker, J. E., Comeau, M. R., & Budelsky, A. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4299 · Cited by 321
Peters, S. P., Jones, C. A., Haselkorn, T., Mink, D. R., Valacer, D. J., & Weiss, S. T. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.022 · Cited by 252
Sergejeva, S., Ivanov, S., Lötvall, J., & Lindén, A. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0213oc · Cited by 184
Airway Eosinophils: Allergic Inflammation Recruited Professional Antigen-Presenting Cells
Wang, H.-B., Ghiran, I., Matthaei, K., & Weller, P. F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7585 · Cited by 174
Papp, K. A., Reid, C., Foley, P. A., Sinclair, R. D., Salinger, D. H., Williams, G., Dong, H., Krueger, J. G., Russell, C. B., & Martin, D. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.163 · Cited by 143
Fukushima, C., Matsuse, H., Tomari, S., Obase, Y., Miyazaki, Y., Shimoda, T., & Kohno, S. (2003) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61870-4 · Cited by 120
Neutrophil Recruitment by Interleukin-17 into Rat Airways In Vivo : Role of Tachykinins
Hoshino, H., Lötvall, J. O., Skoogh, B., & Lindén, A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.5.9806008 · Cited by 95
Targan, S. R., Feagan, B. G., Vermeire, S., Panaccione, R., MELMED, G. Y., Blosch, C. M., Newmark, R., Zhang, N., Chon, Y., Lin, S., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.084 · Cited by 88
Self-citationPhosphoinositide 3-kinase δ inhibitor suppresses interleukin-17 expression in a murine asthma model
Park, S. J., Lee, K. S., Kim, S. R., Min, K. H., Moon, H., Lee, M. H., Chung, C. R., Han, H.-A., Puri, K. D., & Lee, Y. C. (2010) · European Respiratory Journal · doi:10.1183/09031936.00106609 · Cited by 88
Trials and tribulations in identifying new biologic treatments for asthma
Holgate, S. T. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.02.003 · Cited by 49
Self-citationEsophageal Candidiasis—An Adverse Effect of Inhaled Corticosteroids Therapy
Aun, M. V., Ribeiro, M. R., Garcia, C. L. C., Agondi, R. C., Kalil, J. E., & Junior, P. F. G.-B. (2009) · Journal of Asthma · doi:10.1080/02770900902777783 · Cited by 39
Al-Alwan, L. A., Chang, Y., Baglole, C. J., Risse, P., Halayko, A. J., Martin, J. G., Eidelman, D. H., & Hamid, Q. A. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.04.042 · Cited by 38
Cited by
Lambrecht, B. N., & Hammad, H. (2015) · Nature Immunology · doi:10.1038/ni.3049 · Cited by 1,673
The basic immunology of asthma
Hammad, H., & Lambrecht, B. N. (2021) · Cell · doi:10.1016/j.cell.2021.02.016 · Cited by 1,105
After asthma: redefining airways diseases
Pavord, I. D., Beasley, R., Agusti, A., Anderson, G. P., Bel, E., Brusselle, G., Cullinan, P., Custovic, A., Ducharme, F. M., Fahy, J. V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)30879-6 · Cited by 1,073
Lambrecht, B. N., Hammad, H., & Fahy, J. V. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.018 · Cited by 1,039
Neutrophilic Inflammation in Asthma and Association with Disease Severity
Ray, A., & Kolls, J. K. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.07.003 · Cited by 546
Metadata
- Authors
- Busse, W. W., Holgate, S., Kerwin, E., Chon, Y., Feng, J., Lin, J., & Lin, S.-L.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-12-01
- Volume
- 188
- Issue
- 11
- Pages
- 1294-1302
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2019394772
- Cited by
- 666
- References
- 24
- FWCI
- 29.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.